Literature DB >> 25790823

Overcoming the hurdles for a reproducible generation of human functionally mature reprogrammed neurons.

Vania Broccoli1, Alicia Rubio2, Stefano Taverna3, Latefa Yekhlef3.   

Abstract

The advent of cell reprogramming technologies has widely disclosed the possibility to have direct access to human neurons for experimental and biomedical applications. Human pluripotent stem cells can be instructed in vitro to generate specific neuronal cell types as well as different glial cells. Moreover, new approaches of direct neuronal cell reprogramming can strongly accelerate the generation of different neuronal lineages. However, genetic heterogeneity, reprogramming fidelity, and time in culture of the starting cells can still significantly bias their differentiation efficiency and quality of the neuronal progenies. In addition, reprogrammed human neurons exhibit a very slow pace in gaining a full spectrum of functional properties including physiological levels of membrane excitability, sustained and prolonged action potential firing, mature synaptic currents and synaptic plasticity. This delay poses serious limitations for their significance as biological experimental model and screening platform. We will discuss new approaches of neuronal cell differentiation and reprogramming as well as methods to accelerate the maturation and functional activity of the converted human neurons.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Neurons; disease modeling; embryonic stem cells; induced pluripotent stem cells; neuronal activity; synapses

Mesh:

Year:  2015        PMID: 25790823      PMCID: PMC4935208          DOI: 10.1177/1535370215577585

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  48 in total

1.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

2.  Accelerated high-yield generation of limb-innervating motor neurons from human stem cells.

Authors:  Mackenzie W Amoroso; Gist F Croft; Damian J Williams; Sean O'Keeffe; Monica A Carrasco; Anne R Davis; Laurent Roybon; Derek H Oakley; Tom Maniatis; Christopher E Henderson; Hynek Wichterle
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

3.  Neural progenitors from human embryonic stem cells.

Authors:  B E Reubinoff; P Itsykson; T Turetsky; M F Pera; E Reinhartz; A Itzik; T Ben-Hur
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

4.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

5.  Erosion of dosage compensation impacts human iPSC disease modeling.

Authors:  Shila Mekhoubad; Christoph Bock; A Sophie de Boer; Evangelos Kiskinis; Alexander Meissner; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

6.  Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons.

Authors:  Orly L Wapinski; Thomas Vierbuchen; Kun Qu; Qian Yi Lee; Soham Chanda; Daniel R Fuentes; Paul G Giresi; Yi Han Ng; Samuele Marro; Norma F Neff; Daniela Drechsel; Ben Martynoga; Diogo S Castro; Ashley E Webb; Thomas C Südhof; Anne Brunet; Francois Guillemot; Howard Y Chang; Marius Wernig
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

7.  Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.

Authors:  Stuart M Chambers; Yuchen Qi; Yvonne Mica; Gabsang Lee; Xin-Jun Zhang; Lei Niu; James Bilsland; Lishuang Cao; Edward Stevens; Paul Whiting; Song-Hai Shi; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2012-07-01       Impact factor: 54.908

8.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

9.  Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Authors:  Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

10.  Physiological characterisation of human iPS-derived dopaminergic neurons.

Authors:  Elizabeth M Hartfield; Michiko Yamasaki-Mann; Hugo J Ribeiro Fernandes; Jane Vowles; William S James; Sally A Cowley; Richard Wade-Martins
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more
  6 in total

1.  NanoMEA: A Tool for High-Throughput, Electrophysiological Phenotyping of Patterned Excitable Cells.

Authors:  Alec S T Smith; Eunpyo Choi; Kevin Gray; Jesse Macadangdang; Eun Hyun Ahn; Elisa C Clark; Michael A Laflamme; Joseph C Wu; Charles E Murry; Leslie Tung; Deok-Ho Kim
Journal:  Nano Lett       Date:  2019-12-23       Impact factor: 11.189

Review 2.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

Review 3.  The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.

Authors:  Gabriella MacDougall; Logan Y Brown; Boris Kantor; Ornit Chiba-Falek
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

4.  Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement.

Authors:  Kai-Yen Peng; Yu-Wei Lee; Pei-Ju Hsu; Hsiu-Huan Wang; Yun Wang; Jun-Yang Liou; Shan-Hui Hsu; Kenneth K Wu; B Linju Yen
Journal:  Oncotarget       Date:  2016-07-12

5.  Graphene foam as a biocompatible scaffold for culturing human neurons.

Authors:  Giovanna M D'Abaco; Cristiana Mattei; Babak Nasr; Emma J Hudson; Abdullah J Alshawaf; Gursharan Chana; Ian P Everall; Bryony Nayagam; Mirella Dottori; Efstratios Skafidas
Journal:  R Soc Open Sci       Date:  2018-03-07       Impact factor: 2.963

6.  Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration.

Authors:  Daniel I Orellana; Paolo Santambrogio; Alicia Rubio; Latefa Yekhlef; Cinzia Cancellieri; Sabrina Dusi; Serena G Giannelli; Paola Venco; Pietro G Mazzara; Anna Cozzi; Maurizio Ferrari; Barbara Garavaglia; Stefano Taverna; Valeria Tiranti; Vania Broccoli; Sonia Levi
Journal:  EMBO Mol Med       Date:  2016-10-04       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.